Search Results - "Bortolotto, Doriane"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    NADPH Oxidase-1 Plays a Key Role in Keratinocyte Responses to UV Radiation and UVB-Induced Skin Carcinogenesis by Raad, Houssam, Serrano-Sanchez, Martin, Harfouche, Ghida, Mahfouf, Walid, Bortolotto, Doriane, Bergeron, Vanessa, Kasraian, Zeinab, Dousset, Lea, Hosseini, Mohsen, Taieb, Alain, Rezvani, Hamid Reza

    Published in Journal of investigative dermatology (01-06-2017)
    “…The nicotinamide adenine dinucleotide phosphate oxidase (NOX) family enzymes are involved in several physiological functions. However, their roles in…”
    Get full text
    Journal Article
  2. 2

    IDO Targeting in Sarcoma: Biological and Clinical Implications by Nafia, Imane, Toulmonde, Maud, Bortolotto, Doriane, Chaibi, Assia, Bodet, Dominique, Rey, Christophe, Velasco, Valerie, Larmonier, Claire B, Cerf, Loïc, Adam, Julien, Le Loarer, François, Savina, Ariel, Bessede, Alban, Italiano, Antoine

    Published in Frontiers in immunology (05-03-2020)
    “…Sarcomas are heterogeneous malignant mesenchymal neoplasms with limited sensitivity to immunotherapy. We recently demonstrated an increase in Kynurenine…”
    Get full text
    Journal Article
  3. 3

    Abstract 3938: Anti-angiogenic therapy combination with hypoxia-regulating agent leads to improved tumor regression in a murine model or renal carcinoma by Nafia, Imane, Chaibi, Assia, Bortolotto, Doriane, Rey, Christophe, Bessede, Alban

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Background: While antiangiogenic therapies have been shown effective in preclinical and clinical trials, tumors can acquire resistance conferring them…”
    Get full text
    Journal Article
  4. 4

    Abstract 6658: Deciphering anti-PDL1 effect in a syngeneic mouse model of sarcoma by Nafia, Imane, Chaibi, Assia, Bortolotto, Doriane, Rey, Christophe, Italiano, Antoine, Bessede, Alban

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Background: In the context of novel immuno-oncology therapeutics development at preclinical stage, it's crucial to understand the primary features of…”
    Get full text
    Journal Article
  5. 5

    Abstract 622: Development and characterization of a novel anti-PD1 resistant sarcoma mouse model by Nafia, Imane, Guegan, Jean-Philippe, Chaibi, Assia, Bos, Noëlie, Bortolotto, Doriane, Rey, Christophe, Cerf, Loïc, Peyraud, Florent, Italiano, Antoine, Bessede, Alban

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract Background: Soft Tissue Sarcoma (STS) is known to be resistant to cancer immunotherapy including the prototypical immune checkpoint inhibitor (ICI)…”
    Get full text
    Journal Article
  6. 6